Skip to content
MarketScale
‹ Back to IndustriesHealthcare

#WintheDay: How Personal Branding Can Drive Individual and Corporate Performance

Dollars drive healthcare. So much so, in fact, that the US spent more than 19.7% of US GDP on healthcare spending in 2020. Healthcare costs effect everyone involved in the industry, from the payor to the clinician to the patient. To help streamline healthcare solutions, one company aims to match patients with the best…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

Share

 
Dollars drive healthcare. So much so, in fact, that the US spent more than 19.7% of US GDP on healthcare spending in 2020. Healthcare costs effect everyone involved in the industry, from the payor to the clinician to the patient. To help streamline healthcare solutions, one company aims to match patients with the best therapeutic treatments for their individual cases. But what are they doing exactly and how is this disruptive method driving innovation in the sector?  

On today’s episode of Highway to Health, host David Kemp chats with Chase Wasson, a Vice President with CARIS Life Sciences to share his knowledge and experience on personal branding in the healthcare industry. Wasson’s key point: success starts with individualized plans. By using provided data and by analyzing data points themselves, CARIS is parsing out a way to personalize cancer treatments, with a different treatment dependent on each patients’ individual needs. 

“…We’re really at the forefront of revolutionizing care, not only at the patient level but also kind of giving clinicians a blueprint as to which therapeutic is most advantageous for your therapy or, on the counter-end, is this patient, you know, not going to benefit from a particular therapeutic?,” explained Wasson. 

Wasson is the VP of Strategic Accounts with CARIS Life Sciences. Wasson holds over a decade of leadership, sales, and healthcare experience. Prior to CARIS Life Sciences, Wasson was a Director under AstraZeneca, overseeing multiple national accounts within the U.S. market. He is a graduate of Texas State University and holds his MEd in Higher Education from the University of Oklahoma.  

CARIS Life Sciences core practices span multiple facets of the life sciences industry, including DNA and RNA research, Molecular Profiling, and BioPharma solutions. As a leading innovator in molecular science and research, CARIS helps healthcare professionals, patients, and researchers revolutionize cancer care. 

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare AI deployments stall on data quality, not model performance

Healthcare AI deployments stall on data quality, not model performance

Healthcare AI deployments are facing challenges not with the AI models themselves, but with the data quality. Hospital CIOs report difficulties in scaling AI due to fragmented and poorly governed data. This highlights the need for better data management and governance in healthcare AI initiatives.

  • 01Data quality is a major obstacle in scaling healthcare AI deployments.
  • 02Hospital CIOs are encountering issues with fragmented data governance.
  • 03AI model performance is not the primary challenge in these initiatives.

Jul 11, 2026

NHS commits £10bn to health tech, with ambient voice and pathology digitization at the center

NHS commits £10bn to health tech, with ambient voice and pathology digitization at the center

NHS England is investing £10bn in health technology, focusing on ambient voice technology and pathology digitization. This initiative aims to improve healthcare efficiency and patient outcomes. The commitment includes integrating advanced technologies into existing healthcare systems.

  • 01NHS England commits £10bn to health tech.
  • 02Focus areas include ambient voice technology and pathology digitization.
  • 03The initiative aims to enhance healthcare efficiency and patient care.

Jul 9, 2026

Canada launches Vital, a national hospital data platform backed by $210 million, starting with 160 hospitals

Canada launches Vital, a national hospital data platform backed by $210 million, starting with 160 hospitals

Canada has introduced a national hospital data platform named Vital, which will initially connect real-time data from 160 hospitals across three provinces. The initiative is supported by $210 million in funding, with coordination provided by Unity Health Toronto. This platform aims to enhance healthcare data integration and accessibility across the country.

  • 01Vital platform will connect 160 hospitals across three Canadian provinces.
  • 02The initiative is supported by $210 million in funding.
  • 03Unity Health Toronto is coordinating the implementation of this platform.

Jul 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub